13 hours ago • targetedonc.com
FDA Lifts Clinical Hold On Lorigerlimab Trial In Ovarian Cancer
13 hours ago • targetedonc.com
FDA Lifts Clinical Hold On Lorigerlimab Trial In Ovarian Cancer2026-04-15 • medicalxpress.com
Innovative drug plus chemotherapy increases survival rates for platinum resistant ovarian cancer individuals during a trial2026-04-13 • biomedwire.com
LIXTE Biotechnology Holdings Inc. shares rose following interim results from an ovarian cancer trial presented at the SGO Conference.2026-04-13 • PR Newswire
Florida Cancer Specialists and Research Institute’s work leads to a significant advancement broadening treatment possibilities for patients facing recurrent ovarian cancer2026-04-13 • clinicaltrialsarena.com
Verastem Oncology’s treatment combination demonstrates long-term survival for ovarian cancer patients.2026-04-10 • stocktitan.net
Azenosertib 400mg treatment will be central to Zentalis’s (NASDAQ: ZNTL) late-stage ovarian cancer clinical trials.2026-04-10 • in.investing.com
Zentalis is testing a 400mg dosage in its ovarian cancer drug trial2026-04-10 • bioengineer.org
Bispecific Therapy Clinical Trial Shows Promise Against Advanced Ovarian Cancer2026-04-10 • cancernetwork.com
FDA Granted Fast Track to SIM0505 for Platinum-Resistant Ovarian Cancer2026-04-10 • stocktitan.net
Zentalis Pharmaceuticals Reports 400mg Daily 5:2 Azenosertib Alone Demonstrated as the Key Study Dosage for Cyclin E1-Positive Platinum-Resistant Ovarian2026-04-07 • oncodaily.com
The FDA has authorized a novel combined treatment for ovarian cancer that is resistant to platinum drugs – OCRF2026-04-06 • cancernetwork.com
CTIM-76 Granted FDA Fast Track for Platinum-Resistant Ovarian Cancer2026-04-06 • cancernetwork.com
Relacorilant and Nab-Paclitaxel Present a Novel Treatment for Platinum-Resistant Ovarian Cancer2026-04-03 • businesswire.com
European Commission Authorizes KEYTRUDA® (pembrolizumab) Combined with Paclitaxel and Optionally Bevacizumab for Adult Patients with PD-L1 (CPS ≥1) Platinum-2026-04-03 • stocktitan.net
Context Therapeutics Reports CTIM-76 Granted Fast Track Status by the FDA for Platinum Resistant Ovarian Cancer Treatment2026-04-03 • stocktitan.net
FDA approves Fast Track for Context Therapeutics’ CTIM-76 in platinum resistant ovarian cancer2026-04-01 • curetoday.com
FDA Expedites Review of ZW191 for Ovarian Cancer with Platinum Resistance2026-04-01 • in.investing.com
Ernexa to be tested in ovarian cancer trial using cell therapy ERNA-1012026-04-01 • newshub.medianet.com.au
CLEO Achieves Significant Progress as Sample Collection Finishes for Critical U.S. Clinical Trial2026-03-31 • stocktitan.net
Anixa Biosciences will present data from its ovarian cancer CAR-T therapy clinical trial at the Society of Gynecologic Oncology Annual Meeting focused on Women’s Cancer.2026-03-31 • citybuzz.co
LIXTE Biotechnology is broadening its clinical trials of LB-100 for difficult ovarian and colon cancers2026-03-31 • PR Newswire
Anixa Biosciences will present data from its ovarian cancer CAR-T therapy clinical trial at the Society of Gynecologic Oncology Annual Meeting focused on Women's Cancer.2026-03-28 • ehealth.eletsonline.com
Corcept Therapeutics Gains FDA Clearance for Treatment for Ovarian Cancer2026-03-27 • oncologynewscentral.com
FDA Authorizes Relacorilant Blend Treatment for Platinum-Refractory Ovarian Cancer2026-03-26 • manilatimes.net
IMUNON Presents Revised Phase 2 Results Demonstrating Sustained Progress in Median Overall Survival Using IMNN-001 for Women Having Newly Identified Advanced Ovarian Cancer2026-03-25 • pharmiweb.com
OverT Bio Announces Clinical Advisory Board for OVT-101 Development in Ovarian Cancer and Solid Tumors2026-03-24 • EIN Presswire
Elle Simone Scott’s Cookbook Released by National Ovarian Cancer Coalition Following Her Death2026-03-23 • smallcaps.com.au
Cleo Diagnostics Improves Biomarker Panel for Ovarian Cancer Blood Test Prior to FDA Review5 hours ago • prnewswire.co.uk
Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)2026-04-18 • prnewswire.co.uk
Three Papers Published Consecutively in Nature Energy: JinkoSolar's Breakthroughs in TOPCon/Perovskite Tandem Technology Receive Authoritative Recognition2026-04-18 • prnewswire.co.uk
2025 China & Global Development Reports Published in Hainan2026-04-18 • prnewswire.co.uk
Monday’s trading activity boosted leading NASDAQ stocks into the Monad Network’s blockchain, initiating the first tokenized stock trading platform, supported by Anchored.2026-04-18 • ainewswire.com
Rail Vision Ltd. Utilizes Artificial Intelligence and Thermal Imaging to Transform Rail Safety2026-04-18 • prnewswire.co.uk
Knowlej and Chime Initiate Financial Futures Campaign for Students to Boost Confidence and School Involvement2026-04-18 • prnewswire.co.uk
Tranchi AI Launches AI to Assist with Home Purchases2 hours ago • EIN Presswire
Akribis Veins & Vitality Introduces Pelvic Floor Refresh Program Combining EmSella and EmSculpt Neo4 hours ago • EIN Presswire
Graves Law Strengthens Client Advocacy for Florida Car Accident Victims Through Comprehensive Legal Support4 hours ago • EIN Presswire
Food Journal Magazine Unveils Its Latest ‘Best of Los Angeles’ Culinary Discoveries4 hours ago • EIN Presswire
India's Jewellery Market Shows Growing Shift Toward PlatinumStay ahead with real-time headlines from top sources, categorized by sector and country.